Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study
Contributeurs/tricesFriedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; Telenti, A.; Furrer, Hansjakob; Bucher, H. C.; Bernasconi, Enos; Weber, R.
Publié dansAIDS, vol. 15, no. 14, p. 1793-1800
Date de publication2001
Résumé
Mots-clés
- Adult
- Aged
- Anti-HIV Agents/ therapeutic use
- Benzoxazines
- CD4 Lymphocyte Count
- Cohort Studies
- Drug Therapy, Combination
- Female
- HIV Infections/ drug therapy
- HIV Protease Inhibitors/ therapeutic use
- HIV-1/physiology
- Humans
- Male
- Middle Aged
- Oxazines/ therapeutic use
- Prospective Studies
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/ therapeutic use
- Treatment Outcome
- Viral Load
Structure d'affiliation
Citation (format ISO)
FRIEDL, A. C. et al. Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study. In: AIDS, 2001, vol. 15, n° 14, p. 1793–1800. doi: 10.1097/00019048-200111000-00015
Fichiers principaux (1)
Article
Identifiants
- PID : unige:7239
- DOI : 10.1097/00019048-200111000-00015
- PMID : 11579241
ISSN du journal0269-9370